What’s Trump Done on Prescription Drug Prices So Far – and What Might Be Next?
An early move by the president has raised questions about what direction his second-term policy on drug costs will take.
Where $2 prescription drug prices, Obamacare stand in Trump executive order onslaught
Trump stopped a program that had been in the works and was intended to give Medicare recipients access to more than 100 generic drugs for $2 a month, according to another executive order signed on Trump's first day in his new term.
Fox Carolina Investigates: Why prescription drugs prices are so high
Pharmacy benefit managers are the middlemen in the prescription drug market. The Federal Trade Commission reports the revenue of four PBMs exceeds $1 trillion and they control 86% of the market. Meanwhile, the price patients pay for drugs has increased nearly 300% in the last 30 years, according to Peterson-KFF Health System Tracker.
Trump's administration aims for 'greater transparency' in drug price negotiations
The U.S. government said on Wednesday it will aim for "greater transparency" in Medicare drug price negotiations under President Donald Trump's administration following criticism from the pharmaceutical industry for the Biden-era law.
Trump administration affirms drug price talks, but will seek input to ‘improve’ program
A short statement from CMS said the agency will consider ways to make Medicare price negotiations, begun under Biden, more transparent.
Maine bill aims to protect federal drug pricing program
Lawmakers unveiled the bill that requires pharmaceutical manufacturers to sell certain drugs to care centers and pharmacies in underserved areas at a discount.
US govt looks to bring 'greater transparency' in Medicare drug price negotiations
The U.S. government said on Wednesday it will consider opportunities to "bring greater transparency" for the Medicare drug price negotiation program under President Donald Trump's administration. The price negotiation process was established under former President Joe Biden's signature Inflation Reduction Act in 2022.
CMS aiming for more transparency in drug pricing negotiations
The U.S. Centers for Medicare & Medicaid Services, or CMS, said it is considering ways to bring "greater transparency" to the Medicare drug pricing negotiation program mandated under the Inflation Reduction Act of 2022.
Fact Check: Headline on Mark Cuban moving Cost Plus Drugs to California is false
A satirical news headline originally published on SpaceX Mania saying that billionaire Mark Cuban was moving his company Cost ...
How to leverage cash prices and discount cards for prescription drug savings
SaveHealth explores the potential prescription cost savings that can be achieved by leveraging cash prices and discount cards ...
Cigna plans to limit out-of-pocket drug costs for U.S. patients
President Donald Trump in December said he wanted to “knock out the middleman” in drug purchasing.
Fact Check: Insulin cap for Medicare unaffected by Trump order on prescription drug costs
A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe ...
FiercePharma1d
Amid more drug-price scrutiny, biopharma companies largely keep their January hikes in check
As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...
Trump Order Didn’t Reverse All of Biden’s Measures to Lower Drug Costs
President Donald Trump rescinded an executive order issued by former President Joe Biden aimed at finding new models for ...
Cigna taking steps to lower out-of-pocket cost of prescription drugs
(Reuters) -Cigna Group plans to make changes to help lower out-of-pocket cost of prescription drugs, the company said on ...
The Economist2h
The bad side-effects of China’s campaign to cut drug costs
These are some of the problems that doctors have encountered in China’s public hospitals. They have been speaking out in recent weeks, questioning the quality of the country’s drugs and urging reform ...
Sen. Dick Durbin: Big Pharma should disclose prices on drug advertisements
Requiring price disclosures on advertisements for prescription drugs would empower patients and reduce excess spending on ...